Titan Pharmaceuticals
TTNP
#10925
Rank
โ‚น0.58 B
Marketcap
โ‚น439.70
Share price
-3.76%
Change (1 day)
25.61%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น418.72. In 2023 the company made an earnings per share (EPS) of -โ‚น706.77 an increase over its 2022 EPS that were of -โ‚น1,449.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น706.77-51.22%
2022-โ‚น1,449-15.61%
2021-โ‚น1,717-81.37%
2020-โ‚น9,214-77.52%
2019-โ‚น40,994-56.32%
2018-โ‚น93,855-59.51%
2017-โ‚น2,31,822-371.81%
2016โ‚น85,287-144.35%
2015-โ‚น1,92,288300%
2014-โ‚น48,072-121.54%
2013โ‚น2,23,191-151.38%
2012-โ‚น4,34,364-11.54%
2011-โ‚น4,91,021188.89%
2010-โ‚น1,69,969-10%
2009-โ‚น1,88,854
2007-โ‚น7,74,302-2.38%
2006-โ‚น7,93,187-39.13%
2005-โ‚น13,03,093-16.87%
2004-โ‚น15,67,489-22.43%
2003-โ‚น20,20,7394.9%
2002-โ‚น19,26,31261.9%
2001-โ‚น11,89,781-13.7%
2000-โ‚น13,78,63565.01%
1999-โ‚น8,35,499-35.87%
1998-โ‚น13,02,871-1824.71%
1997โ‚น75,542-102.4%
1996-โ‚น31,53,863

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น833.12-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น669.57-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น386.29-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.75-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.89-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น406.32-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA